首页|氨氯地平联合不同他汀类药物治疗高血压并动脉粥样硬化效果比较

氨氯地平联合不同他汀类药物治疗高血压并动脉粥样硬化效果比较

Effect of amlodipine combined with different statins on hypertension complicated by atherosclerosis

扫码查看
目的 比较氨氯地平分别联合不同剂量阿托伐他汀、辛伐他汀治疗高血压并动脉粥样硬化的效果.方法 回顾性分析济南市第二人民医院2019年8月至2020年8月诊治的高血压并动脉粥样硬化患者100例的临床资料,根据治疗方案不同分为对照组32例(氨氯地平联合辛伐他汀治疗)、研究1组34例(氨氯地平联合10 mg/d阿托伐他汀治疗)、研究2组34例(氨氯地平联合20 mg/d阿托伐他汀治疗),三组均治疗6个月.比较三组临床疗效、血脂水平、血压水平、氧化应激水平、颈动脉内膜中层厚度及斑块面积的差异.结果 对照组、研究1组、研究2组总有效率分别为71.88%(23/32)、82.35%(28/34)、91.18%(31/34),三组总有效率差异有统计学意义(x2=4.16,P<0.05).治疗后,三组总胆固醇、三酰甘油、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、24 h动态血压、昼间血压、夜间血压、丙二醛、超氧化物歧化酶、谷胱甘肽过氧化物酶、颈动脉内膜中层厚度、斑块面积差异均有统计学意义(F=-19.54、-76.61、11.15、-56.83、-147.35、-23.10、-11.47、-11.65、-128.36、-15.60、-24.52、25.61、118.99、-59.23、-81.64,均P<0.05).对照组、研究1组、研究2组不良反应发生率分别为12.50%(4/32)、8.82%(3/34)、11.76%(4/34),三组间差异无统计学意义(x2=0.25,P=0.611).结论 氨氯地平联合阿托伐他汀治疗高血压合并动脉粥样硬化疗效更佳,且高剂量的阿托伐他汀在降脂、控制血压、改善机体氧化应激水平及临床症状等方面效果更加明显.
Objective To explore the effects of amlodipine combined with different doses of atorvastatin and simvastatin on hypertension complicated by atherosclerosis.Methods A retrospective analysis was conducted on the clinical data of 100 patients with hypertension complicated by atherosclerosis who were diagnosed and treated at Jinan 2nd People's Hospital from August 2019 to August 2020.These patients were divided into control group(n=32,amlodipine combined with simvastatin),study group 1(n=34,amlodipine combined with 10 mg/day atorvastatin),and study group 2(n=34,amlodipine combined with 20 mg/day atorvastatin)according to different treatment schemes.All three groups were treated for 6 months.The clinical efficacy,blood lipid level,blood pressure,oxidative stress level,carotid intima-media thickness and plaque area were compared among the three groups.Results The overall response rates of the control group,study group 1,and study group 2 were 71.88%(23/32),82.35%(28/34),and 91.18%(31/34),respectively.The difference in overall response rate among the three groups was statistically significant(x2=4.16,P<0.05).After treatment,total cholesterol,triglycerides,high-density lipoprotein cholesterol,low-density lipoprotein cholesterol,24-hour dynamic blood pressure,diurnal blood pressure,nighttime blood pressure,malondialdehyde,superoxide dismutase,glutathione peroxidase,carotid intima-media thickness and plaque area were statistically different among the three groups(F=-19.54,-76.61,11.15,-56.83,-147.35,-23.10,-11.47,-11.65,-128.36,-15.60,-24.52,25.61,118.99,-59.23,-81.64,all P<0.05).The incidence rates of adverse reactions in the control group,study group 1,and study group 2 were 12.50%(4/32),8.82%(3/34),and 11.76%(4/34),respectively.There was no statistically significant difference among the three groups(x2=0.25,P=0.611).Conclusion Amlodipine combined with atorvastatin is more effective in the treatment of hypertension complicated by atherosclerosis than the amlodipine combined with simvastatin.High-dose atorvastatin is more effective in reducing lipid,controlling blood pressure,improving the level of oxidative stress and clinical symptoms compared with low-dose atorvastatin.

HypertensionAtherosclerosisDrug therapy,combinationAmlodipineAtorvastatinSimvastatinTreatment outcomeRetrospective studies

冯莹

展开 >

济南市第二人民医院内科,济南 250000

高血压 动脉粥样硬化 药物疗法,联合 氨氯地平 阿托伐他汀 辛伐他汀 治疗结果 回顾性研究

2024

中国基层医药
中华医学会,安徽医科大学

中国基层医药

影响因子:1.003
ISSN:1008-6706
年,卷(期):2024.31(1)
  • 13